Wanbury Limited specializes in Pharmaceuticals within the Healthcare sector.
Wanbury Limited, with Security Code 524212, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Date Begin | Date End | Net Sales | Net Profit | Total Income | Diluted EPS for continuing operation | Other Expenses | Other Income | Depreciation and amortisation expense | Profit (+)/ Loss (-) from Ordinary Activities before Tax |
|---|---|---|---|---|---|---|---|---|---|
| 2024-01-01 | 2024-03-31 | 1394.06 | 336.33 | 1403.31 | 2.37 | 306.81 | 9.25 | 32.8 | 339.05 |
| 2023-10-01 | 2023-12-31 | 1,454.97 | 102.73 | 1,461.89 | 3.14 | -288.90 | 6.93 | -33.23 | 102.56 |
| 2023-10-01 | 2023-12-31 | 1,454.97 | 102.73 | 1,461.89 | 3.13 | -288.91 | 6.92 | -33.23 | 102.55 |
| 2023-07-01 | 2023-09-30 | 1,444.62 | 73.62 | 1,452.18 | 2.25 | -296.93 | 7.56 | -32.43 | 71.86 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 8% |
| 3 Years: | 14% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 26% |
| 3 Years: | 61% |
| TTM: | 401% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 64% |
| 3 Years: | 23% |
| 1 Year: | 178% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 8% |
| 3 Years: | 14% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 27% |
| 3 Years: | 65% |
| TTM: | 414% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 64% |
| 3 Years: | 23% |
| 1 Year: | 178% |
